Financhill
Sell
32

VRSK Quote, Financials, Valuation and Earnings

Last price:
$222.87
Seasonality move :
3.46%
Day range:
$219.21 - $223.02
52-week range:
$197.00 - $322.92
Dividend yield:
0.82%
P/E ratio:
33.53x
P/S ratio:
10.20x
P/B ratio:
81.25x
Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-19.71%
Market cap:
$30.6B
Revenue:
$2.9B
EPS (TTM):
$6.55

Analysts' Opinion

  • Consensus Rating
    Verisk Analytics, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 9 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $249.81, Verisk Analytics, Inc. has an estimated upside of 13.33% from its current price of $219.61.
  • Price Target Downside
    According to analysts, the lowest downside price target is $195.00 representing 11.21% downside risk from its current price of $219.61.

Fair Value

  • According to the consensus of 14 analysts, Verisk Analytics, Inc. has 13.33% upside to fair value with a price target of $249.81 per share.

VRSK vs. S&P 500

  • Over the past 5 trading days, Verisk Analytics, Inc. has underperformed the S&P 500 by -3% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Verisk Analytics, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Verisk Analytics, Inc. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Verisk Analytics, Inc. reported revenues of $768.3M.

Earnings Growth

  • Verisk Analytics, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Verisk Analytics, Inc. reported earnings per share of $1.61.
Enterprise value:
33.4B
EV / Invested capital:
--
Price / LTM sales:
10.20x
EV / EBIT:
24.71x
EV / Revenue:
11.02x
PEG ratio (5yr expected):
16.07x
EV / Free cash flow:
29.92x
Price / Operating cash flow:
27.69x
Enterprise value / EBITDA:
19.93x
Gross Profit (TTM):
$1.8B
Return On Assets:
18.3%
Net Income Margin (TTM):
30.19%
Return On Equity:
373.73%
Return On Invested Capital:
22.89%
Operating Margin:
45.53%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $2.6B $2.8B $3B $725.3M $768.3M
Gross Profit $1.5B $1.6B $1.8B $425.5M $456.5M
Operating Income $1.2B $1.2B $1.4B $311.7M $349.8M
EBITDA $1.4B $1.5B $1.7B $388.1M $432.1M
Diluted EPS $3.40 $6.42 $6.55 $1.54 $1.61
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $934.1M $918.4M $928.2M $1.1B $2.7B
Total Assets $7.7B $7B $4.4B $4.6B $6.2B
Current Liabilities $1.8B $2B $784.1M $1.3B $2.3B
Total Liabilities $4.9B $5B $4B $4.3B $5.9B
Total Equity $2.7B $2B $395.2M $304.7M $377.5M
Total Debt $3B $2.6B $3.1B $3.2B $4.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $1.1B $1.1B $1.3B $296.2M $403.5M
Cash From Investing $2.7B -$133.4M -$421.3M -$52.6M -$234.5M
Cash From Financing -$3.7B -$953.3M $709.3M -$421.3M $1.3B
Free Cash Flow $803.9M $916.2M $1.1B $240.7M $336.1M
VRSK
Sector
Market Cap
$30.6B
$486.4M
Price % of 52-Week High
68.01%
81.97%
Dividend Yield
0.82%
0%
Shareholder Yield
1.59%
1.52%
1-Year Price Total Return
-19.71%
--
Beta (5-Year)
0.807
0.533
Dividend yield:
0.82%
Annualized payout:
$1.56
Payout ratio:
27.93%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $221.96
200-day SMA
Sell
Level $267.22
Bollinger Bands (100)
Sell
Level 217.13 - 255.95
Chaikin Money Flow
Buy
Level 179.6M
20-day SMA
Buy
Level $219.45
Relative Strength Index (RSI14)
Sell
Level 46.72
ADX Line
Sell
Level 16.37
Williams %R
Neutral
Level -67.247
50-day SMA
Sell
Level $219.80
MACD (12, 26)
Sell
Level -0.07
25-day Aroon Oscillator
Sell
Level -20
On Balance Volume
Neutral
Level 271.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (9.4961)
Sell
CA Score (Annual)
Level (-0.9499)
Buy
Beneish M-Score (Annual)
Level (-2.4734)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.8544)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Verisk Analytics, Inc. engages in the provision of data, analytics, and technology services. The firm also offers predictive analytics and decision support solutions to clients in rating, underwriting, claims, catastrophe, and weather risk fields. It operates through the Insurance segment. The Insurance segment offers fraud-detection solutions including review of data on claim histories, analysis of claims to find emerging patterns of fraud, and identification of suspicious claims in the insurance sector and offers solutions and services primarily through annual subscriptions or long-term agreements. The company was founded in 1971 and is headquartered in Jersey City, NJ.

Stock Forecast FAQ

In the current month, VRSK has received 4 Buy ratings 9 Hold ratings, and 1 Sell ratings. The VRSK average analyst price target in the past 3 months is $249.81.

  • Where Will Verisk Analytics, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Verisk Analytics, Inc. share price will rise to $249.81 per share over the next 12 months.

  • What Do Analysts Say About Verisk Analytics, Inc.?

    Analysts are divided on their view about Verisk Analytics, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Verisk Analytics, Inc. is a Sell and believe this share price will drop from its current level to $195.00.

  • What Is Verisk Analytics, Inc.'s Price Target?

    The price target for Verisk Analytics, Inc. over the next 1-year time period is forecast to be $249.81 according to 14 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.

  • Is VRSK A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Verisk Analytics, Inc. is a Hold. 9 of 14 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of VRSK?

    You can purchase shares of Verisk Analytics, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Verisk Analytics, Inc. shares.

  • What Is The Verisk Analytics, Inc. Share Price Today?

    Verisk Analytics, Inc. was last trading at $222.87 per share. This represents the most recent stock quote for Verisk Analytics, Inc.. Yesterday, Verisk Analytics, Inc. closed at $219.61 per share.

  • How To Buy Verisk Analytics, Inc. Stock Online?

    In order to purchase Verisk Analytics, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock